08 September 2003
Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress
Panagiotis Korantzopoulos, Theofilos Kolettis, Kostas Siogas, John GoudevenosMed Sci Monit 2003; 9(9): RA225-229 :: ID: 13210
Abstract
Atrial fibrillation (AF) represents the most common arrhythmia encountered in clinical practice. The pathophysiology of AF is complex, but in most cases it may be caused by multiple random re-entering wavelets. As generally known, the development of AF leads to electrophysiological and cellular changes in the atria that tend to sustain AF, a process known as electrical remodeling. In addition, it has been proposed that electrical remodeling contributes to the high incidence of early recurrence of AF after cardioversion. The principal characteristics of this process are the shortening of the refractory period with increased dispersion, the loss of rate adaptation, and the reduction of atrial conductivity. On the molecular level, calcium accumulation in myocytes seems to trigger electrophysiological changes leading to reduction in the intensity of L-type calcium current. Currently, the role of inflammation and oxidative stress on electrical remodeling is under investigation. C-reactive protein (CRP), a major inflammatory marker, has been found to be increased in both persistent and paroxysmal AF. Additionally, CRP may have prognostic significance regarding successful cardioversion of AF, and may predict recurrences of arrhythmia. On the other hand, it has been demonstrated that increased oxidative damage occurs in the atria of AF patients and may contribute to electrical remodeling. Interestingly, a prodromal antioxidant intervention study showed beneficial effects from vitamin C on incidence of postoperative AF. The role of inflammation and oxidative stress in AF deserves further study, since amelioration of atrial electrical remodeling by conventional antiarrhythmics has been proved ineffective.
Keywords: Inflammation - physiopathology
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952